Richard Saynor

Experienced and enthusiastic leader; loves pioneering access for patients and driving innovation in classic & established medicines. CEO @Sandoz_Global

[Richard Saynor @SaynorRichard]

Today marks the start of this year’s World Antimicrobial Awareness Week. Read my latest article on busting some myths around drug resistance: https://t.co/BN8QgFCe8k

[GGB Awards @GGB_Awards]

The Award for Regulatory Achievement of the Year goes to… Sandoz! Congratulations on your well-deserved win! #GGBAwards

[GGB Awards @GGB_Awards]

And the winner is Sandoz for the Acquisition of the Year award, sponsored by Adalvo, for their second win of the night! #GGBAwards

[Richard Saynor @SaynorRichard]

Thank you for the great discussion, @donatopmancini. This yrs theme @ftlive conference is essential for us as leaders in healthcare industry. It was great to talk about the central role of #Biosimilars in resolving the pandemics longtail access crisis. #FTPharma @ft

[Financial Times Live @ftlive]

Biosimilars have been around for 15 years in Europe and 5 in the US. Are we seeing the uptake we hoped for? What progress has been made to date in adding access, sustainability and savings to the healthcare system? #FTPharma book now: https://t.co/FK9oYlu6bn

[Richard Saynor @SaynorRichard]

Great news on how we continue our efforts to combat #COVID19. Since the onset of the pandemic #Sandoz has committed extensive breadth of potential treatment options & manufacturing resources to this global challenge. Proud to collaborate w/ @BioNTech_Group https://t.co/JHPbC7tFfY

[Richard Saynor @SaynorRichard]

At #Sandoz we believe #antibiotics are the backbone of modern medicine & we are investing accordingly. Today, we are proud to announce the successful completion of our planned #acquisition of @GSK’s global cephalosporins portfolio. Read my thoughts: https://t.co/sTtcM4nVj1

[Richard Saynor @SaynorRichard]

I am happy to welcome Claire as the new Head of Global Product Development. I look forward to working with Claire to continue driving our purpose of pioneering access for patients worldwide. #sandoz #PioneeringAccessForPatients

[Devex @devex]

Watch this discussion on stopping the silent pandemic: Ramping up action on antimicrobial resistance with @SaynorRichard @Sandoz_Global, and Lutz Hegemann @Novartis.

#DevexEvent @ #UNGA76 with @Novartis @NovartisGH #silentpandemic #globalhealth
https://t.co/IbfQ0VN6N3

[Richard Saynor @SaynorRichard]

Thx for the discussion @JennyLeiRavelo. As I never tire of pointing out antibiotics are the backbone of modern healthcare & we need to do everything we can to keep them that way-particularly given the growing threat of AMR which many call “silent pandemic” https://t.co/ArBuzlqONX

[Richard Saynor @SaynorRichard]

Looking forward to the discussion @Devex on why modern healthcare is almost unimaginable without functioning antibiotics why AMR poses a real & growing threat to their use & how we #Sandoz & @NovartisGH are joining forces w/ partners to do something about this before its too late

[Devex @devex]

Join us as Lutz Hegemann, Head of Corporate Affairs & Global Health, @novartis, and Richard Saynor, CEO, @Sandoz_Global, discuss ramping up action against antimicrobial resistance.

#DevexEvent @ #UNGA76 with @Novartis #silentpandemic #globalhealth #onehealth

[Richard Saynor @SaynorRichard]

Check out my latest article: Keeping healthcare sustainable: Let’s start by challenging the assumptions https://t.co/WrTjHHdOyQ via @LinkedIn

[Richard Saynor @SaynorRichard]

Today, Sandoz has announced a binding agreement to acquire Aspen's Japanese business of off-patent medicines: https://t.co/sAqgvG03OV

[Richard Saynor @SaynorRichard]

Check out my latest article: How to succeed in generics: It’s simple, but... https://t.co/y3CLfnSyGZ via @LinkedIn

[Richard Saynor @SaynorRichard]

NEWS: Sandoz announces global deal to commercialize proposed key #MultipleSclerosis (#MS) #biosimilar medicine
https://t.co/mHBCeFRjfX #NovartisNews

[Richard Saynor @SaynorRichard]

Biosimilars are the “new generics” and more needs to be done in the US to help patients more fully benefit from them. Check out my perspective. #sandoz #biosimilars #makingaccesshappen https://t.co/wjcwI5SoXf